In a report released today, Mitchell Germain from JMP Securities maintained a Hold rating on EPR Properties (EPR – Research Report). The ...

In a report released today, Andrew Boone from JMP Securities reiterated a Buy rating on Maplebear (CART – Research Report), with a price target ...

Fintel reports that on April 8, 2025, JMP Securities upgraded their outlook for Ares Management Corporation - Preferred Security (NYSE:ARES.PRB) from Market Perform to Market Outperform.

Chewy (NYSE:CHWY – Get Free Report) had its price objective cut by investment analysts at JMP Securities from $40.00 to $39.00 in a note issued to investors on Monday,Benzinga reports.

JMP Securities reissued their market outperform rating on shares of Cytokinetics (NASDAQ:CYTK – Free Report) in a report released on Thursday morning,Benzinga reports. The brokerage currently ...

Fintel reports that on April 8, 2025, JMP Securities upgraded their outlook for Blackstone (BMV:BX) from Market Perform to Market Outperform. There are 1,364 funds or institutions reporting ...

Fintel reports that on April 8, 2025, JMP Securities upgraded their outlook for Evercore (NYSE:EVR) from Market Perform to Market Outperform. Analyst Price Forecast Suggests 81.85% Upside As of ...

Monday, JMP Securities reiterated its Market Perform rating on Adicet Bio Inc. (NASDAQ:ACET) without setting a new price target. The stock has faced significant headwinds, declining 73% over the ...

Fintel reports that on April 10, 2025, JMP Securities initiated coverage of MBX Biosciences (NasdaqGS:MBX) with a Market Outperform recommendation. Analyst Price Forecast Suggests 493.67% Upside ...

In addition to JMP Securities, Alphabet Class A also received a Hold from Rosenblatt Securities’s Barton Crockett in a report issued on March 19. However, yesterday, Guggenheim maintained a Buy ...

In addition to JMP Securities, Alphabet Class A also received a Hold from Cantor Fitzgerald’s Deepak Mathivanan in a report issued on April 8. However, yesterday, KeyBanc maintained a Buy rating ...

Monday, JMP Securities reiterated its Market Perform rating on Adicet Bio Inc. (NASDAQ:ACET) without setting a new price target. The stock has faced significant headwinds, declining 73% over the past ...